{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:36:59Z","timestamp":1790818619454,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several obstacles to the production, expansion and genetic modification of immunotherapeutic T cells in vitro have restricted the widespread use of T-cell immunotherapy. In the context of HSCT, delayed na\u00efve T-cell recovery contributes to poor outcomes. A novel approach to overcome the major limitations of both T-cell immunotherapy and HSCT would be to transplant human T-lymphoid progenitors (HTLPs), allowing reconstitution of a fully functional na\u00efve T-cell pool in the patient thymus. However, it is challenging to produce HTLPs in the high numbers required to meet clinical needs. Here, we found that adding tumor necrosis factor alpha (TNF\u03b1) to a DL-4-based culture system led to the generation of a large number of nonmodified or genetically modified HTLPs possessing highly efficient in vitro and in vivo T-cell potential from either CB HSPCs or mPB HSPCs through accelerated T-cell differentiation and enhanced HTLP cell cycling and survival. This study provides a clinically suitable cell culture platform to generate high numbers of clinically potent nonmodified or genetically modified HTLPs for accelerating immune recovery after HSCT and for T-cell-based immunotherapy (including CAR T-cell therapy).<\/jats:p>","DOI":"10.1038\/s41423-021-00706-8","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T07:04:01Z","timestamp":1623395041000},"page":"1662-1676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A DL-4- and TNF\u03b1-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors"],"prefix":"10.1038","volume":"18","author":[{"given":"Ranjita Devi","family":"Moirangthem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Lizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cordesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8286-8601","authenticated-orcid":false,"given":"Juliette","family":"Olivr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"de Chappedelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-9448","authenticated-orcid":false,"given":"Agata","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Cagnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-6101","authenticated-orcid":false,"given":"Antonio","family":"Rausell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-0288","authenticated-orcid":false,"given":"Tom","family":"Taghon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J. T.","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Pflumio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Six","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Lagresle-Peyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Soheili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"706_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1389201019666180418095526","volume":"19","author":"AN Miliotou","year":"2018","unstructured":"Miliotou, A. N. & Papadopoulou, L. C. CAR T-cell therapy: a new era in cancer immunotherapy. Curr. Pharm. Biotechnol. 19, 5\u201318 (2018).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"706_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fimmu.2020.00361","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi, J., Ding, C., Jiang, X. & Gao, Y. Advances in developing CAR T-cell therapy for HIV cure. Front. Immunol. 11, 361 (2020).","journal-title":"Front. Immunol."},{"key":"706_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3389\/fimmu.2020.00792","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Prospects of the use of cell therapy to induce immune tolerance. Front. Immunol. 11, 792 (2020).","journal-title":"Front. Immunol."},{"key":"706_CR4","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3389\/fimmu.2018.02359","volume":"9","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Chimeric antigen receptor (CAR) treg: a promising approach to inducing immunological tolerance. Front. Immunol. 9, 2359 (2018).","journal-title":"Front. Immunol."},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 2545\u20132554 (2017).","journal-title":"N. Engl. J. Med."},{"key":"706_CR6","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1002\/ajh.25399","volume":"94","author":"W Qasim","year":"2019","unstructured":"Qasim, W. Allogeneic CAR T cell therapies for leukemia. Am. J. Hematol. 94, S50\u2013S54 (2019).","journal-title":"Am. J. Hematol."},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11684-019-0714-8","volume":"13","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Management of cytokine release syndrome related to CAR-T cell therapy. Front. Med. 13, 610\u2013617 (2019).","journal-title":"Front. Med."},{"key":"706_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2013.00054","volume":"4","author":"E Clave","year":"2013","unstructured":"Clave, E. et al. Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse. Front. Immunol. 4, 54 (2013).","journal-title":"Front. Immunol."},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","volume":"19","author":"IH Bartelink","year":"2013","unstructured":"Bartelink, I. H. et al. Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children. Biol. Blood Marrow Transplant. 19, 305\u2013313 (2013).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"706_CR10","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1182\/blood.V90.12.4705","volume":"90","author":"J Storek","year":"1997","unstructured":"Storek, J. et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90, 4705\u20134709 (1997).","journal-title":"Blood"},{"key":"706_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4049\/jimmunol.1601100","volume":"198","author":"MS Chaudhry","year":"2017","unstructured":"Chaudhry, M. S., Velardi, E., Malard, F. & van den Brink, M. R. M. Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T Up the thymus. J. Immunol. 198, 40\u201346 (2017).","journal-title":"J. Immunol."},{"key":"706_CR12","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1084\/jem.20080134","volume":"205","author":"K Hozumi","year":"2008","unstructured":"Hozumi, K. et al. Delta-like 4 is indispensable in thymic environment specific for T cell development. J. Exp. Med. 205, 2507\u20132513 (2008).","journal-title":"J. Exp. Med."},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1084\/jem.20080829","volume":"205","author":"U Koch","year":"2008","unstructured":"Koch, U. et al. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205, 2515\u20132523 (2008).","journal-title":"J. Exp. Med."},{"key":"706_CR14","first-page":"75","volume":"360","author":"T Taghon","year":"2012","unstructured":"Taghon, T., Waegemans, E. & Van de Walle, I. Notch signaling during human T cell development. Curr. Top. Microbiol. Immunol. 360, 75\u201397 (2012).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"706_CR15","doi-asserted-by":"publisher","first-page":"a028621","DOI":"10.1101\/cshperspect.a028621","volume":"10","author":"H Hosokawa","year":"2018","unstructured":"Hosokawa, H. & Rothenberg, E. V. Cytokines, transcription factors, and the initiation of T-cell development. Cold Spring Harb. Perspect. Biol. 10, a028621 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"706_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bcmd.2011.04.001","volume":"47","author":"EM Six","year":"2011","unstructured":"Six, E. M. et al. Cytokines and culture medium have a major impact on human in vitro T-cell differentiation. Blood Cells Mol. Dis. 47, 72\u201378 (2011).","journal-title":"Blood Cells Mol. Dis."},{"key":"706_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1615\/CritRevImmunol.v25.i2.40","volume":"25","author":"TM Schmitt","year":"2005","unstructured":"Schmitt, T. M. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. Thymus-derived signals regulate early T-cell development. Crit. Rev. Immunol. 25, 141\u2013159 (2005).","journal-title":"Crit. Rev. Immunol."},{"key":"706_CR18","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1182\/blood-2007-08-106294","volume":"111","author":"Q-L Hao","year":"2008","unstructured":"Hao, Q.-L. et al. Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Blood 111, 1318\u20131326 (2008).","journal-title":"Blood"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1182\/blood-2005-08-3412","volume":"107","author":"F Weerkamp","year":"2006","unstructured":"Weerkamp, F. et al. Human thymus contains multipotent progenitors with T\/B lymphoid, myeloid, and erythroid lineage potential. Blood 107, 3131\u20133137 (2006).","journal-title":"Blood"},{"key":"706_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/stem.1145","volume":"30","author":"C Reimann","year":"2012","unstructured":"Reimann, C. et al. Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD\/SCID\/\u03b3c(-\/-) mice. Stem Cells 30, 1771\u20131780 (2012).","journal-title":"Stem Cells"},{"key":"706_CR21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaci.2017.10.034","volume":"141","author":"L Simons","year":"2018","unstructured":"Simons, L. et al. Generation of adult human T-cell progenitors for immunotherapeutic applications. J. Allergy Clin. Immunol. 141, 1491\u20131494.e4 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"706_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcyt.2012.10.014","volume":"15","author":"SM Carlin","year":"2013","unstructured":"Carlin, S. M., Ma, D. D. & Moore, J. J. T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists. Cytotherapy 15, 224\u2013230 (2013).","journal-title":"Cytotherapy"},{"key":"706_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1191536","volume":"329","author":"AE Boitano","year":"2010","unstructured":"Boitano, A. E. et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329, 1345\u20131348 (2010).","journal-title":"Science"},{"key":"706_CR24","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1182\/bloodadvances.2018026575","volume":"3","author":"J Singh","year":"2019","unstructured":"Singh, J. et al. Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic progenitor cells. Blood Adv. 3, 2934\u20132948 (2019).","journal-title":"Blood Adv."},{"key":"706_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1256337","volume":"345","author":"I Fares","year":"2014","unstructured":"Fares, I. et al. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345, 1509\u20131512 (2014).","journal-title":"Science"},{"key":"706_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1189\/jlb.1TA0214-121RR","volume":"96","author":"MJAJ Huijskens","year":"2014","unstructured":"Huijskens, M. J. A. J. et al. Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells. J. Leukoc. Biol. 96, 1165\u20131175 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"706_CR27","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1182\/blood.V95.9.2806.009k01_2806_2812","volume":"95","author":"SF Weekx","year":"2000","unstructured":"Weekx, S. F. et al. Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alpha. Blood 95, 2806\u20132812 (2000).","journal-title":"Blood"},{"key":"706_CR28","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.exphem.2007.04.009","volume":"35","author":"K Smits","year":"2007","unstructured":"Smits, K. et al. Tumor necrosis factor promotes T-cell at the expense of B-cell lymphoid development from cultured human CD34+ cord blood cells. Exp. Hematol. 35, 1272\u20131278 (2007).","journal-title":"Exp. Hematol."},{"key":"706_CR29","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1084\/jem.20071003","volume":"204","author":"EM Six","year":"2007","unstructured":"Six, E. M. et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J. Exp. Med 204, 3085\u20133093 (2007).","journal-title":"J. Exp. Med"},{"key":"706_CR30","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen, J. J. M. et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257\u20132317 (2003).","journal-title":"Leukemia"},{"key":"706_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","volume":"24","author":"EV Rothenberg","year":"2012","unstructured":"Rothenberg, E. V. Transcriptional drivers of the T-cell lineage program. Curr. Opin. Immunol. 24, 132\u2013138 (2012).","journal-title":"Curr. Opin. Immunol."},{"key":"706_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbamcr.2010.10.010","volume":"1813","author":"L Portt","year":"2011","unstructured":"Portt, L., Norman, G., Clapp, C., Greenwood, M. & Greenwood, M. T. Anti-apoptosis and cell survival: a review. Biochim. Biophys. Acta 1813, 238\u2013259 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"706_CR33","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.febslet.2010.05.061","volume":"584","author":"LW Thomas","year":"2010","unstructured":"Thomas, L. W., Lam, C. & Edwards, S. W. Mcl-1; the molecular regulation of protein function. FEBS Lett. 584, 2981\u20132989 (2010).","journal-title":"FEBS Lett."},{"key":"706_CR34","first-page":"74","volume":"50","author":"I Andr\u00e9","year":"2019","unstructured":"Andr\u00e9, I. et al. Ex vivo generated lymphoid progenitors for immune reconstitution in the context of allogeneic transplantation and gene therapy [Abstract]. Focis W. 50, 74 (2019).","journal-title":"Focis W."},{"key":"706_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0006-291X(05)81384-1","volume":"181","author":"M K\u00f6rner","year":"1991","unstructured":"K\u00f6rner, M., Tarantino, N. & Debr\u00e9, P. Constitutive activation of NF-kB in human thymocytes. Biochemical Biophysical Res. Commun. 181, 80\u201386 (1991).","journal-title":"Biochemical Biophysical Res. Commun."},{"key":"706_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbmt.2014.11.675","volume":"21","author":"M Robin","year":"2015","unstructured":"Robin, M. et al. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party. Biol. Blood Marrow Transplant. 21, 489\u2013495 (2015).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"706_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1634\/stemcells.21-2-143","volume":"21","author":"K Yasui","year":"2003","unstructured":"Yasui, K., Matsumoto, K., Hirayama, F., Tani, Y. & Nakano, T. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation. Stem Cells 21, 143\u2013151 (2003).","journal-title":"Stem Cells"},{"key":"706_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet, C. S. et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods 14, 521\u2013530 (2017).","journal-title":"Nat. Methods"},{"key":"706_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nmeth.4258","volume":"14","author":"S Shukla","year":"2017","unstructured":"Shukla, S. et al. Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1. Nat. Methods 14, 531\u2013538 (2017).","journal-title":"Nat. Methods"},{"key":"706_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/stem.448","volume":"28","author":"M Pearl-Yafe","year":"2010","unstructured":"Pearl-Yafe, M. et al. Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment. Stem Cells 28, 1270\u20131280 (2010).","journal-title":"Stem Cells"},{"key":"706_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.exphem.2007.07.010","volume":"35","author":"M Pearl-Yafe","year":"2007","unstructured":"Pearl-Yafe, M. et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp. Hematol. 35, 1601\u20131612 (2007).","journal-title":"Exp. Hematol."},{"key":"706_CR42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/leu.2010.97","volume":"24","author":"K Mizrahi","year":"2010","unstructured":"Mizrahi, K. et al. Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation. Leukemia 24, 1325\u20131334 (2010).","journal-title":"Leukemia"},{"key":"706_CR43","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1182\/blood.V98.7.2091","volume":"98","author":"S Fukuda","year":"2001","unstructured":"Fukuda, S. & Pelus, L. M. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 98, 2091\u20132100 (2001).","journal-title":"Blood"},{"key":"706_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0006-2952(03)00490-8","volume":"66","author":"U Gaur","year":"2003","unstructured":"Gaur, U. & Aggarwal, B. B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 66, 1403\u20131408 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"706_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/10428199609045713","volume":"24","author":"K Nagafuji","year":"1996","unstructured":"Nagafuji, K., Takenaka, K., Shibuya, T., Harada, M. & Niho, Y. Fas antigen (CD95) and hematopoietic progenitor cells. Leuk. Lymphoma 24, 43\u201356 (1996).","journal-title":"Leuk. Lymphoma"},{"key":"706_CR46","first-page":"66","volume":"5","author":"B Backx","year":"1991","unstructured":"Backx, B., Broeders, L., Bot, F. J. & L\u00f6wenberg, B. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia 5, 66\u201370 (1991).","journal-title":"Leukemia"},{"key":"706_CR47","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/bmt.2014.12","volume":"49","author":"K Mizrahi","year":"2014","unstructured":"Mizrahi, K., Yaniv, I., Ash, S., Stein, J. & Askenasy, N. Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts. Bone Marrow Transplant. 49, 640\u2013648 (2014).","journal-title":"Bone Marrow Transplant."},{"key":"706_CR48","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1073\/pnas.89.11.4864","volume":"89","author":"BP Giroir","year":"1992","unstructured":"Giroir, B. P., Brown, T. & Beutler, B. Constitutive synthesis of tumor necrosis factor in the thymus. Proc. Natl Acad. Sci. USA. 89, 4864\u20134868 (1992).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"706_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.molimm.2016.02.015","volume":"72","author":"R Bichele","year":"2016","unstructured":"Bichele, R., Kisand, K., Peterson, P. & Laan, M. TNF superfamily members play distinct roles in shaping the thymic stromal microenvironment. Mol. Immunol. 72, 92\u2013102 (2016).","journal-title":"Mol. Immunol."},{"key":"706_CR50","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/ni.2849","volume":"15","author":"SA Mahmud","year":"2014","unstructured":"Mahmud, S. A. et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat. Immunol. 15, 473\u2013481 (2014).","journal-title":"Nat. Immunol."},{"key":"706_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/labinvest.3700700","volume":"88","author":"C Osipo","year":"2008","unstructured":"Osipo, C., Golde, T. E., Osborne, B. A. & Miele, L. A. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab. Invest. 88, 11\u201317 (2008).","journal-title":"Lab. Invest."},{"key":"706_CR52","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. & Baldwin, A. S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680\u20131683 (1998).","journal-title":"Science"},{"key":"706_CR53","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1371\/journal.ppat.0020004","volume":"2","author":"MM Rahman","year":"2006","unstructured":"Rahman, M. M. & McFadden, G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2, e4 (2006).","journal-title":"PLoS Pathog."},{"key":"706_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","volume":"6","author":"SY Kim","year":"2010","unstructured":"Kim, S. Y. & Solomon, D. H. Tumor necrosis factor blockade and the risk of viral infection. Nat. Rev. Rheumatol. 6, 165\u2013174 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"706_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DHPS.S28801","volume":"5","author":"T Ali","year":"2013","unstructured":"Ali, T. et al. Clinical use of anti-TNF therapy and increased risk of infections. Drug Health. Patient Saf. 5, 79\u201399 (2013).","journal-title":"Drug Health. Patient Saf."},{"key":"706_CR56","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/323816a0","volume":"323","author":"J Mestan","year":"1986","unstructured":"Mestan, J. et al. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816\u2013819 (1986).","journal-title":"Nature"},{"key":"706_CR57","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1128\/jvi.70.11.7388-7397.1996","volume":"70","author":"G Herbein","year":"1996","unstructured":"Herbein, G., Montaner, L. J. & Gordon, S. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J. Virol. 70, 7388\u20137397 (1996).","journal-title":"J. Virol."},{"key":"706_CR58","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.4049\/jimmunol.163.7.3653","volume":"163","author":"BR Lane","year":"1999","unstructured":"Lane, B. R. et al. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163, 3653\u20133661 (1999).","journal-title":"J. Immunol."},{"key":"706_CR59","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/323819a0","volume":"323","author":"GH Wong","year":"1986","unstructured":"Wong, G. H. & Goeddel, D. V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323, 819\u2013822 (1986).","journal-title":"Nature"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00706-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T21:05:17Z","timestamp":1675458317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00706-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1038\/s41423-021-00706-8","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.A. and M.C. are the co-founders of the biotech company Smart Immune. T.S. and L.S. are currently working for Smart Immune, Plc. The authors have no additional financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}